List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 20 studies with search of: "ArQule" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
Conditions: Pancreatic Cancer;   Adenocarcinoma
Intervention: Drug: ARQ 501 in combination with gemcitabine
2 Recruiting A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors
Condition: Cancer
Intervention: Drug: ARQ 197
3 Completed A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Neoplasms
Interventions: Drug: ARQ 197;   Drug: gemcitabine
4 Recruiting Phase 2 Study in Patients With MiT Tumors
Conditions: Renal Cell Carcinoma (RCC);   Alveolar Soft Part Sarcoma (ASPS);   Clear Cell Sarcoma (CCS)
Intervention: Drug: ARQ 197
5 Recruiting A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors
Condition: Cancer, Advanced Solid Tumors
Intervention: Drug: ARQ 197
6 Recruiting A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Interventions: Drug: ARQ 197;   Drug: Erlotinib
7 Completed Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
Condition: Cancer
Intervention: Drug: ARQ 501
8 Active, not recruiting An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: ARQ 501
9 Completed A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: ARQ 501
10 Completed ARQ 501 in Subjects With Cancer
Condition: Cancer
Intervention: Drug: ARQ 501
11 Completed A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) Genotype
Condition: Healthy
Intervention: Drug: Treatment with ARQ 197
12 Suspended A Study of ARQ 171 in Patients With Advanced Solid Tumors
Condition: Cancer
Intervention: Drug: ARQ 171
13 Recruiting Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: Treatment with ARQ 197 in combination with gemcitabine
14 Completed Bioequivalence Study of ARQ 197 Amorphous and Crystalline Polymorphs A and B in Normal Healthy Volunteers
Condition: Healthy
Intervention: Drug: ARQ 197
15 Recruiting Safety Study of ARQ 197 in Cirrhotic Patients With Carcinoma (HCC)
Conditions: Cirrhosis;   Hepatocellular Carcinoma
Intervention: Drug: ARQ 197
16 Completed An Extension Study for Patients Previously Treated With ARQ 501
Condition: Cancer
Intervention: Drug: ARQ 501
17 Recruiting ARQ 197 in Subjects With Metastatic Solid Tumors
Conditions: Cancer;   Tumor
Intervention: Drug: ARQ 197
18 Recruiting Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: Treatment with ARQ 197 in combination with sorafenib
19 Recruiting Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: ARQ 621
20 Completed ARQ 501 in Combination With Docetaxel in Patients With Cancer
Condition: Carcinoma
Intervention: Drug: ARQ 501

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services